Altimmune Inc (ALT)

12.92 +0.89  +7.40% NASDAQ Sep 25, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/13/2020 Misc Altimmune Inc Third Quarter Earnings Conference Call for 2020
11/13/2020 Earnings Altimmune Inc Third Quarter Earnings for 2020 Release
09/24/2020 10:00 EDT Misc Altimmune Inc Annual General Meeting for 2019
08/12/2020 08:30 EDT Misc Altimmune Inc Second Quarter Earnings Conference Call for 2020
08/12/2020 Earnings Altimmune Inc Second Quarter Earnings Result for 2020
05/14/2020 08:30 EDT Misc Altimmune Inc First Quarter Earnings Conference Call for 2020
05/14/2020 Earnings Altimmune Inc First Quarter Earnings Result for 2020
03/27/2020 08:30 EDT Misc Altimmune Inc Fourth Quarter Earnings Conference Call for 2019
03/27/2020 Misc Altimmune Inc Annual Report for 2019
03/25/2020 16:30 EDT Earnings Altimmune Inc Fourth Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.altimmune.com
  • Investor Relations URL: http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 13, 2020
  • Last Earnings Release: Aug. 12, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jan. 20, 2017
  • Description: Altimmune Inc is a United States-based clinical-stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of liver diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, and NasoShield. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.